Unasyn Injection, Powder, For Solution
NDC Package 0049-0013-83
Package Information
Unasyn (ampicillin sodium and sulbactam sodium) injection is this combination medication is used to treat a wide variety of bacterial infections. This formulation utilizes a injection, powder, for solution delivery system. Marketed by Roerig, this product is identified by NDC 0049-0013 and is authorized under FDA application NDA050608.
Identification & Billing
- RxCUI: 1659592 - ampicillin / sulbactam 1.5 GM Injection
- RxCUI: 1659592 - ampicillin 1000 MG / sulbactam 500 MG Injection
- RxCUI: 1659592 - ampicillin (as ampicillin sodium) 1 GM / sulbactam (as sulbactam sodium) 0.5 GM Injection
- RxCUI: 1659592 - ampicillin 1 GM / sulbactam 0.5 GM Injection
- RxCUI: 1659595 - Unasyn 1.5 GM Injection
Clinical Specifications
- Intramuscular - Administration within a muscle.
- Intravenous - Administration within or into a vein or veins.
Regulatory & Marketing
Hierarchy Structure
- 0049 - Roerig
- 0049-0013 - Unasyn
- 0049-0013-83 - 10 VIAL in 1 CARTON / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (0049-0013-81)
- 0049-0013 - Unasyn
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0049-0013-83 identifies a specific commercial package of 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial (0049-0013-81) of Unasyn, a human prescription drug labeled by Roerig. This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package. This injection, powder, for solution is formulated for intramuscular; intravenous use and contains ampicillin sodium; sulbactam sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Roerig on November 22, 1991. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This combination medication is used to treat a wide variety of bacterial infections. It is known as a penicillin-type antibiotic. It works by stopping the growth of bacteria.
How is this Roerig product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00049001383. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.
